China's Top Drug Distributors Are Soaring: China Earnings Round Up (Part 2)
SHANGHAI - China's drug distribution market and retail pharmacy revenue reached RMB 708 billion ($110.9 billion) in 2010, a 24.6% increase from 2009, and the top three drug distributors' market share increased by 5.8% to 26.7% through aggressive acquisitions to expand their distribution networks, according to China's Ministry of Commerce.
More from Archive
More from Scrip
• By
Plus deals involving TandemAI/Perpetual Medicines, Biocytogen/BeOne, Chugai/Gero, CStone/Istituto Gentili, Alembic/Utility, Brii/Joincare, HanchorBio/Henlius, Rakuten/Cyntec and more.
• By
The osteogenesis imperfecta drug stumbled in a second interim analysis.
Recent moves in the industry include C-suite changes at Essential Pharma, plus Kyverna Therapeutics gets new chief financial officer from Alector.